Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05070741 · ClinicalTrials.gov registry record · NA

Heat Shock Therapy to Improve Mitochondrial Function in Neuropathy

A NA study, sponsored by University of Kansas Medical Center.

Terminated
Registry status
NA
Development phase
3
Enrollment target

NCT05070741 is a NA study that was terminated before completion, run by University of Kansas Medical Center. The registered enrollment target is 3 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05070741, a NA study, was terminated before completion, sponsored by University of Kansas Medical Center.

TERMINATED
Registry status
NA
Development phase
3 participants
Enrollment target

Study Summary

Sensory dysfunction as a result of peripheral nerve damage is a significant problem that leads to reduced quality of life for patients. The prevalence of sensory dysfunction in peripheral neuropathy associates with epidemic increases in prediabetes and diabetes, but also is relevant to chemotherapy treatments and genetic disorders. Clinical approaches to treat peripheral neuropathy and to stimulate axon growth in settings of peripheral axon loss are limited. Although new drugs will hopefully be forthcoming, the most promising approaches likely involve behavioral and lifestyle interventions. Mitochondrial dysfunction is emerging as a key cellular contribution to peripheral axon health and peripheral neuropathy. Mitochondrial deficiencies contribute to neuropathy and include impaired mitochondrial problems with trafficking, mitophagy, fission, and biogenesis. All of these are thought to lead to a bioenergetic crisis, ending in distal axonal degeneration, sensory dysfunction and pain. Heat shock proteins play a critically important role in cellular homeostasis and increasing heat shock protein functions within cells leads to a range of positive improvements, particularly in mitochondria. In addition, new evidence suggests that increasing heat shock protein responses in peripheral nerves has powerful, positive impacts on sensory function and neuropathy. Our interdisciplinary team will investigate the role of mitochondrial dysfunction in peripheral neuropathy and translate these approaches to improve treatment for patients with peripheral neuropathy. The investigators hypothesize that novel heat treatment interventions that improve mitochondrial function will improve metabolic symptoms and peripheral nerve mitochondria, leading to improvements in sensory function, via heat shock protein induction. The investigators will employ immersion heat treatment to elevate heat shock protein responses that induce positive changes in peripheral nerve mitochondria. One aspect is to

Interventions

  • BEHAVIORAL Heat Therapy

Trial Details

FieldValue
Enrollment Target 3 participants
Start Date 2020-07-27
Est. Completion 2022-07-11
Phase NA

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT05070741

The ClinicalTrials.gov registry entry for NCT05070741 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Heat Therapy is the first listed.

NCT05070741 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05070741 about?

NCT05070741 is a clinical study titled "Heat Shock Therapy to Improve Mitochondrial Function in Neuropathy". Sensory dysfunction as a result of peripheral nerve damage is a significant problem that leads to reduced quality of life for patients. The prevalence of sensory dysfunction in peripheral neuropathy associates with epidemic increases in prediabetes and diabetes, but also is relevant to chemotherapy ...

What is the current status of trial NCT05070741?

This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2020-07-27. Estimated completion is 2022-07-11.

What interventions are being tested in trial NCT05070741?

The interventions under investigation include: Heat Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT05070741?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.